4//SEC Filing
Bench David 4
Accession 0000930413-21-000037
CIK 0000316253other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:37 PM ET
Size
5.9 KB
Accession
0000930413-21-000037
Insider Transaction Report
Form 4
Bench David
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (to acquire Common Stock)
2021-01-11+55,400→ 110,800 totalExercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 55,400 stock options. The stock options have a three-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
- [F2]Does not include 15,000 Performance Stock Units granted to the Reporting Person on February 24, 2020, which will vest, if at all, based on (i) the achievement of certain average revenue growth and average adjusted EBITDA growth goals on February 24, 2023 and (ii) the continued employment of the Reporting Person through February 24, 2023.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001797876
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 9:37 PM ET
- Size
- 5.9 KB